BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18085502)

  • 1. Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial.
    Teixeira PF; Reuters VS; Ferreira MM; Almeida CP; Reis FA; Melo BA; Buescu A; Costa AJ; Vaisman M
    Horm Metab Res; 2008 Jan; 40(1):50-5. PubMed ID: 18085502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure.
    Teixeira Pde F; Reuters VS; Ferreira MM; Almeida CP; Reis FA; Buescu A; Costa AJ; Vaisman M
    Transl Res; 2008 Apr; 151(4):224-31. PubMed ID: 18355770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation response and effectiveness of thyroid hormone replacement treatment on lipid profile and function in elderly patients with subclinical hypothyroidism.
    Arinzon Z; Zuta A; Peisakh A; Feldman J; Berner Y
    Arch Gerontol Geriatr; 2007; 44(1):13-9. PubMed ID: 16621071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological functions and metabolic aspects in subclinical hypothyroidism: the effects of L-thyroxine.
    Baldini M; Colasanti A; Orsatti A; Airaghi L; Mauri MC; Cappellini MD
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):854-9. PubMed ID: 19389454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized Trial.
    Blum MR; Gencer B; Adam L; Feller M; Collet TH; da Costa BR; Moutzouri E; Dopheide J; Depairon M; Sykiotis GP; Kearney P; Gussekloo J; Westendorp R; Stott DJ; Bauer DC; Rodondi N
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2988-2997. PubMed ID: 29846630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of treatment with levothyroxine in the lipid profile of the patients with subclinical hypothyroidism].
    Prats Julià M
    Endocrinol Nutr; 2009 Jan; 56(1):13-7. PubMed ID: 19627704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroid diseases, dyslipidemia and cardiovascular risk].
    Jiskra J; Límanová Z; Antosová M
    Vnitr Lek; 2007 Apr; 53(4):382-5. PubMed ID: 17578170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism.
    Ravanbod M; Asadipooya K; Kalantarhormozi M; Nabipour I; Omrani GR
    Am J Med; 2013 May; 126(5):420-4. PubMed ID: 23582934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial.
    Roos A; Linn-Rasker SP; van Domburg RT; Tijssen JP; Berghout A
    Arch Intern Med; 2005 Aug 8-22; 165(15):1714-20. PubMed ID: 16087818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose tolerance and lipid profile in longterm exogenous subclinical hyperthyroidism and the effects of restoration of euthyroidism, a randomised controlled trial.
    Heemstra KA; Smit JW; Eustatia-Rutten CF; Heijboer AC; Frölich M; Romijn JA; Corssmit EP
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):737-44. PubMed ID: 17121524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial.
    Valizadeh M; Seyyed-Majidi MR; Hajibeigloo H; Momtazi S; Musavinasab N; Hayatbakhsh MR
    Endocr Res; 2009; 34(3):80-9. PubMed ID: 19701833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with levothyroxine and liothyronine in two ratios, compared with levothyroxine monotherapy in primary hypothyroidism: a double-blind, randomized, controlled clinical trial.
    Appelhof BC; Fliers E; Wekking EM; Schene AH; Huyser J; Tijssen JG; Endert E; van Weert HC; Wiersinga WM
    J Clin Endocrinol Metab; 2005 May; 90(5):2666-74. PubMed ID: 15705921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can levothyroxine treatment reduce urinary albumin excretion rate in patients with early type 2 diabetic nephropathy and subclinical hypothyroidism? A randomized double-blind and placebo-controlled study.
    Liu P; Liu R; Chen X; Chen Y; Wang D; Zhang F; Wang Y
    Curr Med Res Opin; 2015 Dec; 31(12):2233-40. PubMed ID: 26366481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subclinical hypothyroidism and arteriosclerosis].
    Földes J; Bános C; Winkler G
    Orv Hetil; 2004 Aug; 145(31):1601-7. PubMed ID: 15384857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
    Cakal E; Turgut AT; Demirbas B; Ozkaya M; Cakal B; Serter R; Aral Y
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):294-300. PubMed ID: 19085705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: a randomized, double-blind, controlled study.
    Cinemre H; Bilir C; Gokosmanoglu F; Bahcebasi T
    J Clin Endocrinol Metab; 2009 Jan; 94(1):151-6. PubMed ID: 18984662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depressive symptoms in patients with subclinical hypothyroidism--the effect of treatment with levothyroxine: a double-blind randomized clinical trial.
    Najafi L; Malek M; Hadian A; Ebrahim Valojerdi A; Khamseh ME; Aghili R
    Endocr Res; 2015; 40(3):121-6. PubMed ID: 25775223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Should depressive symptoms in patients with subclinical hypothyroidism be treated with thyroid hormone?].
    van Harten AC; Leue C; Verhey FR
    Tijdschr Psychiatr; 2008; 50(8):539-43. PubMed ID: 18688779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological, hematological, and glycemia effects of dietary supplementation with Agaricus sylvaticus on patients' colorectal cancer.
    Fortes RC; Novaes MR; Recôva VL; Melo AL
    Exp Biol Med (Maywood); 2009 Jan; 234(1):53-62. PubMed ID: 18997106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.